| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.DIABRES.2011.01.022 |
| P698 | PubMed publication ID | 21376417 |
| P2093 | author name string | Hye S Chung | |
| Tae K Kim | |||
| Chang S Yoon | |||
| Jeong H Park | |||
| Mi K Kim | |||
| Min J Kwon | |||
| Soon H Lee | |||
| Byoung D Rhee | |||
| Hye J Jun | |||
| Ji H Suk | |||
| Jung H Ko | |||
| Min K Oh | |||
| P433 | issue | 3 | |
| P921 | main subject | glucose | Q37525 |
| insulin glargine | Q417317 | ||
| type 2 diabetes | Q3025883 | ||
| P304 | page(s) | 322-328 | |
| P577 | publication date | 2011-03-03 | |
| P1433 | published in | Diabetes Research and Clinical Practice | Q15750054 |
| P1476 | title | Nateglinide and acarbose for postprandial glucose control after optimizing fasting glucose with insulin glargine in patients with type 2 diabetes | |
| P478 | volume | 92 |
| Q34563587 | Achieving glycemic control in elderly patients with type 2 diabetes: a critical comparison of current options |
| Q47176512 | Antihyperglycemic Agent Therapy for Adult Patients with Type 2 Diabetes Mellitus 2017: A Position Statement of the Korean Diabetes Association |
| Q47094226 | Antihyperglycemic agent therapy for adult patients with type 2 diabetes mellitus 2017: a position statement of the Korean Diabetes Association |
| Q51320964 | Clinical effectiveness of Novolin® 30R versus Lantus® combined with Glucobay® treatment in elderly patients with type 2 diabetes mellitus controlled by oral hypoglycaemic agents: A randomized study. |
| Q33464541 | Combined use of basal insulin analog and acarbose reduces postprandial glucose in patients with uncontrolled type 2 diabetes |
| Q37473701 | Comparison of acarbose and voglibose in diabetes patients who are inadequately controlled with basal insulin treatment: randomized, parallel, open-label, active-controlled study |
| Q41288368 | Effect of co-ingestion of amino acids with rice on glycaemic and insulinaemic response. |
| Q37565282 | Effects of nateglinide and acarbose on glycemic excursions in standardized carbohydrate and mixed-meal tests in drug-naïve type 2 diabetic patients |
| Q51346223 | Improved post-prandial ghrelin response by nateglinide or acarbose therapy contributes to glucose stability in Type 2 diabetic patients. |
| Q33629805 | Improvement of both fasting and postprandial glycemic control by the two-step addition of miglitol and mitiglinide to basal insulin therapy: a pilot study |
| Q39350860 | Improving postprandial hyperglycemia in patients with type 2 diabetes already on basal insulin therapy: Review of current strategies |
| Q36316219 | Influence of Acarbose on Plasma Glucose Fluctuations in Insulin-Treated Patients with Type 2 Diabetes: A Pilot Study |
| Q36899873 | Nateglinide and acarbose are comparably effective reducers of postprandial glycemic excursions in chinese antihyperglycemic agent-naive subjects with type 2 diabetes |
| Q39101008 | Rationale for treatment options for mealtime glucose control in patients with type 2 diabetes |
| Q26852590 | The Role of Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Understanding How Data Can Inform Clinical Practice in Korea |
| Q38563239 | Therapeutic potential of α-glucosidase inhibitors in type 2 diabetes mellitus: an evidence-based review |
| Q36423072 | α-Glucosidase inhibitors and their use in clinical practice |
Search more.